MDMA-Assisted Therapy with Dr. Scott Shannon, Principal Investigator for MAPS Phase 3 Clinical Trial
VirtualLocationThursday October 26, 2023 @ 6:00 pm – 7:00 pm MST MAPS recently published the results of their Phase 3B MDMA […]
Menu
Loading view.
Webinars you can't miss, & in-person events like integration circles and open houses to help guide
you in the psychedelic industry and space!
you in the psychedelic industry and space!
Events
Mastery of Experience with Dr. Mark Atkinson
VirtualLocation"Mastery of Experience" with Dr. Mark Atkinson Come and meet Dr. Mark Atkinson, internationally-renowned pioneer in the field of human potential development […]
Ketamine-Assisted Therapy For Addiction with Dr. Aviva Fohrer
VirtualLocationThursday November 16, 2023 @ 6:00 pm – 7:00 pm MST Ketamine possesses the potential to disrupt detrimental behavioral patterns, particularly those intertwined […]
ATMA 2024 Roadmap
VirtualLocationThursday December 7, 2023 @ 6:00 pm – 7:00 pm MDT Join our network and begin offering psychedelic-assisted therapy to much needed […]
The Evolution of Psychedelic Clinics in Canada in 2024
VirtualLocationSponsored by ATMA, this webinar will help assist practitioners wishing to provide Psychedelic-assisted therapy (PaT). This webinar will answer these 2 important […]
3 Essentials of an Effective Compassionate Witness (A Guide for Non-licensed Practitioners)
VirtualLocationRegister Here Embarking on the journey to become an effective compassionate witness in the psychedelic realm is akin to transforming into […]
Balancing Safety and Access: MDMA Therapy from Research to Practice
VirtualLocationRegister Here Join Dr. Scott Shannon (MAPS principal investigator on its Phase 3 MDMA Clinical Trial), and ATMA CEO, Vu Tran to learn more about […]
Puppets + Psychedelics on Bicycle Day
VirtualLocationRegister Here Join us for an exclusive fireside chat with the visionary team behind the Psychedelic Puppet Show while we come […]
Psychedelics: A Visual Odyssey
VirtualLocationRegister Here Join us on as epic visual trip as we talk to author, professor, and Canadian historian, Dr Erika Dyck about her […]
ATMA Journey Phase II Psilocybin Clinical Trial Townhall
VirtualLocationATMA’s Phase II Psilocybin-assisted Therapy Clinical Trial has now received a No Objection Letter from Health Canada, as well as approval from […]
Efficacy & Benefits of Group Psilocybin Administration
VirtualLocationThe group therapy hypothesis suggests that group sessions enhance social connectedness and well-being by fostering communitas, psychological safety, empathy, cooperation, and aiding […]
A Sustainable Model of Regulated Psychedelic-assisted Therapy For Clinicians and Clinics
VirtualLocationIf you are a clinician, therapist, holistic practitioner, nurse, social worker, or a clinic owner interested in psychedelic-assisted therapy but don't […]
BACK TO TOP
